We are live on
!
Find out more
HCM
Horan Capital Management Portfolio holdings
AUM
$794M
1-Year Est. Return
30.86%
This Fund
S&P 500
This Quarter
Est. Return
+4.38%
1 Year Est. Return
+30.86%
3 Year Est. Return
+69.18%
5 Year Est. Return
+124.11%
10 Year Est. Return
–
AUM
$387M
AUM Growth
+$9.79M
(+2.6%)
Cap. Flow
-$3.27M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
45.22%
Holding
63
New
8
Increased
14
Reduced
38
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.6M |
| 2 |
Gilead Sciences
GILD
|
+$5.43M |
| 3 |
CERN
Cerner Corp
CERN
|
+$1.7M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.18M |
| 5 |
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
|
+$782K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$5.94M |
| 2 |
Fastenal
FAST
|
+$4.28M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.89M |
| 4 |
C.H. Robinson
CHRW
|
+$2.66M |
| 5 |
Bank of America
BAC
|
+$822K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.92% |
| 2 | Technology | 16.98% |
| 3 | Industrials | 13.28% |
| 4 | Healthcare | 11.31% |
| 5 | Consumer Discretionary | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
ExxonMobil
XOM
$644B
| $768K | 0.2% |
8,519
-7,976
| -48% | -$697K |
|
52
Paychex
PAYX
$41.6B
| $576K | 0.15% |
9,466
+263
| +3% | +$15.2K |
|
|
WBA
53
DELISTED
Walgreens Boots Alliance
WBA
| $555K | 0.14% |
6,707
-1,369
| -17% | -$113K |
|
54
CVS Health
CVS
$133B
| $479K | 0.12% |
6,076
-573
| -9% | -$46.4K |
|
55
iShares Core S&P 500 ETF
IVV
$884B
| $474K | 0.12% |
2,110
-50
| -2% | -$11K |
|
56
Yum China
YUMC
$16.5B
| $424K | 0.11% |
+16,239
| New | +$442K |
|
57
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
| $243K | 0.06% |
2,417
| – | – |
|
|
ATSG
58
DELISTED
Air Transport Services Group
ATSG
| $159K | 0.04% |
+10,000
| New | +$154K |
|
59
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.12B
| $153K | 0.04% |
+3,074
| New | +$154K |
|
60
Medtronic
MDT
$109B
| $136K | 0.04% |
+1,912
| New | +$150K |
|
61
3M
MMM
$90.9B
| $101K | 0.03% |
+682
| New | +$98.4K |
|
62
Under Armour
UAA
$2.84B
| – | – |
-6,394
| Closed | -$247K |
|
|
ESRX
63
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-84,165
| Closed | -$5.94M |
|
Similar funds
DBC
BII
HCMNY
DK
AVAX
IVA
LCM
WEC
Horan Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Horan Capital Management held 63 positions worth $387M, up 2.6% from $377M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Horan Capital Management's Q4 2016 filing shows 8 new, 14 increased, 38 reduced and 2 closed positions. Its largest new stake was Allergan plc: 31,881 shares worth $6.7M. The largest sale was Express Scripts Holding Company, an estimated $5.94M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.
- Horan Capital Management's largest Q4 2016 buy was Allergan plc: 31,881 shares worth $6.7M.
- Horan Capital Management added most to Gilead Sciences in Q4 2016, an estimated $5.43M increase.
- Horan Capital Management's biggest Q4 2016 reduction was Fastenal, cutting an estimated $4.28M.
- Horan Capital Management fully exited Express Scripts Holding Company in Q4 2016, selling an estimated $5.94M.
- Horan Capital Management's ten largest holdings make up 45% of its $387M portfolio in Q4 2016.
- Horan Capital Management opened 8 new positions and closed 2 in Q4 2016.
- Horan Capital Management's portfolio value rose 2.6% quarter-over-quarter to $387M.
Based on Horan Capital Management's 13F filing for Q4 2016, filed 18 Jan 2017.